Research Article
SN-38 Sensitizes BRCA-Proficient Ovarian Cancers to PARP Inhibitors through Inhibiting Homologous Recombination Repair
Figure 4
SN-38 and olaparib combination cause BRCA-proficient ovarian cancer cells apoptosis. A2780 cells were treated with 40 μM olaparib, 10 μM SN-38, or their combination as indicated, and cell apoptosis was analyzed at 48 hrs after treatment by annexin V staining (a, b) and western blot (c) analysis of cleaved caspase 3. Data were represented as the , per group. , by 2-tailed -test.
(a) |
(b) |
(c) |